Interesting TER Put And Call Options For March 13th

The article outlines two option strategies for Teradyne (TER) around the current share price of $244.79: selling a $240 put (bid $17.00) which sets an effective purchase basis of $223.00 and carries a 61% probability of expiring worthless, delivering a 7.08% return on cash or 60.18% annualized (YieldBoost); and writing a $260 covered call (bid $18.00) which would produce a 13.57% total return if called at the March 13 expiration and a 7.35% premium boost (62.48% annualized) if the call expires worthless (52% odds). Implied volatility for the put and call are ~68% and ~70% respectively versus a trailing 12-month volatility of 58%; Stock Options Channel will track contract odds and histories on its site.

Analysis

Market structure: The option data shows two obvious beneficiaries — option premium sellers and prospective long investors using puts to lower entry cost. Selling the Mar13 $240 put for $17 yields an effective buy at $223 (9% below spot) with a stated ~61% chance to expire worthless; market makers and volatility sellers capture IV (~69%) that is ~11pts above realized (58%), signaling rich hedging demand in semicap/test equipment flows.

Risk assessment: Near-term (days–weeks) the trade is governed by theta and IV moves — a 10–15 vol-point swing will materially change P/L; short-term catalysts include TER earnings or a sector capex print. Tail risks are a semiconductor capex shock, regulatory export restrictions, or a rapid rate repricing that hits tech multiples; longer-term risks (quarters) are secular demand shifts in automation/testing that would change earnings power.

Trade implications: Direct actionable structures are clear — sell-to-open $240 puts (effective $223) or buy-and-covered-call $260 for a 13.6% to-expiry capped upside; implied vol premium makes selling attractive but assignment and capital tie-up are real costs. Prefer defined-risk put-credit spreads (sell $240 / buy $230) to cap downside while harvesting most premium; consider pair trades (long TER / short AMAT) to isolate test-equipment outperformance versus fab-capex exposure.

Contrarian angles: Consensus leans toward simple premium harvesting but underrates IV reversion and event gamma — if no negative catalyst IV should compress toward 58%, benefiting sellers but hurting new long option buyers. The market may be underpricing assignment friction: repeated put-selling could force concentrated long stock positions if a broad sell-off hits, so cap position sizes and use defined-risk structures or roll rules.

Key Decisions for Investors

• Sell-to-open Mar13 TER $240 puts (1–3 contracts per trade) to create a potential long at $223 effective cost; cap exposure to 1–2% of portfolio value, treat each contract as $24,000 notional, and close/roll if TER < $220 or implied vol rises >15 vol points.
• Buy TER shares up to 1–2% portfolio weight at current levels (~$244.79) and sell Mar13 $260 calls for $18 (covered-call); target 13.6% to-expiry return, buy back call if stock > $260 or if TER falls below $225, and take profits if stock rises >10% intraperiod.
• Prefer defined-risk credit spread over naked puts: sell Mar13 $240 / buy $230 put to cap max loss at $10/share; allocate no more than 1% portfolio to this spread and close/roll if TER < $230 or IV compresses >10 vol points.
• Implement a small relative-value pair: long TER (0.5–1% weight) versus short AMAT (0.5–1%) to express test/automation outperformance vs fab-equipment cyclicality; unwind within 3 months or if TER underperforms by 8% relative or a material sector capex datapoint prints.